An investigation on behalf of investors in Mirati Therapeutics, Inc. (NASDAQ:MRTX) shares over potential wrongdoing at Mirati Therapeutics, Inc. was announced.

San Diego, CA -- (SBWire) -- 12/07/2021 --Certain directors of Mirati Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Mirati Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Diego, CA based Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. reported that its annual Total Revenue rose from $3.33 million in 2019 to $13.39 million in 2020, and that its Net Loss increased from $212.25 million in 2019 to $357.93 million in 2020.

On November 1, 2021, Mirati Therapeutics, Inc. in an SEC filing, disclosed that certain executives would no longer be serving in their positions. In the filing, the Company stated, "

On October 28, 2021, it was determined that Daniel R. Faga would cease serving as the Executive Vice President, Chief Operating Officer and principal financial officer of Mirati Therapeutics, Inc. (the "Company") and that Joseph Leveque would cease serving as the Company's Executive Vice President and Chief Medical Officer, effective as of November 1, 2021."

Shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) declined from $195.99 per share on October 25, 2021, to $127.12 per share on December 6, 2021.

Those who purchased shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.